Skip to main content
Erschienen in: Intensive Care Medicine 8/2016

25.05.2016 | Correspondence

The Canadian guidelines for the withdrawal of life-sustaining treatment: the role of evidence

verfasst von: Mohamed Y. Rady, Joseph L. Verheijde

Erschienen in: Intensive Care Medicine | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
2.
Zurück zum Zitat Rady MY, Verheijde JL (2016) The standardization approach in end-of-life withdrawal of life-sustaining treatment: sacrificing patient’s safety and the quality of care. J Intensive Care Med 31(4):290–292CrossRefPubMed Rady MY, Verheijde JL (2016) The standardization approach in end-of-life withdrawal of life-sustaining treatment: sacrificing patient’s safety and the quality of care. J Intensive Care Med 31(4):290–292CrossRefPubMed
3.
Zurück zum Zitat Barnes H, McDonald J, Smallwood N, Manser R (2016) Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev 3:CD011008. doi:10.1002/14651858.CD011008.pub2 PubMed Barnes H, McDonald J, Smallwood N, Manser R (2016) Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev 3:CD011008. doi:10.​1002/​14651858.​CD011008.​pub2 PubMed
4.
Zurück zum Zitat Franken LG, Masman AD, de Winter BCM, Koch BCP, Baar FPM, Tibboel D, van Gelder T, Mathot RAA (2016) Pharmacokinetics of morphine, morphine-3-glucuronide and morphine-6-glucuronide in terminally ill adult patients. Clin Pharmacokinet 55:697–709. doi:10.1007/s40262-015-0345-4 CrossRefPubMed Franken LG, Masman AD, de Winter BCM, Koch BCP, Baar FPM, Tibboel D, van Gelder T, Mathot RAA (2016) Pharmacokinetics of morphine, morphine-3-glucuronide and morphine-6-glucuronide in terminally ill adult patients. Clin Pharmacokinet 55:697–709. doi:10.​1007/​s40262-015-0345-4 CrossRefPubMed
5.
Zurück zum Zitat Chan JD, Treece PD, Engelberg RA, Crowley L, Rubenfeld GD, Steinberg KP, Curtis JR (2004) Narcotic and benzodiazepine use after withdrawal of life support: association with time to death? Chest 126(1):286–293CrossRefPubMed Chan JD, Treece PD, Engelberg RA, Crowley L, Rubenfeld GD, Steinberg KP, Curtis JR (2004) Narcotic and benzodiazepine use after withdrawal of life support: association with time to death? Chest 126(1):286–293CrossRefPubMed
6.
Zurück zum Zitat Lin KJ, Ching A, Edmonds KP, Roeland EJ, Revta C, Ma JD, Atayee RS (2015) Variable patterns of continuous morphine infusions at end of life. J Palliat Med 18(9):786–789CrossRefPubMed Lin KJ, Ching A, Edmonds KP, Roeland EJ, Revta C, Ma JD, Atayee RS (2015) Variable patterns of continuous morphine infusions at end of life. J Palliat Med 18(9):786–789CrossRefPubMed
Metadaten
Titel
The Canadian guidelines for the withdrawal of life-sustaining treatment: the role of evidence
verfasst von
Mohamed Y. Rady
Joseph L. Verheijde
Publikationsdatum
25.05.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 8/2016
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-016-4372-x

Weitere Artikel der Ausgabe 8/2016

Intensive Care Medicine 8/2016 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.